Insulin is an important risk factor of endometrial cancer among premenopausal women: a case-control study in China.
The aim of the article was to evaluate the important role played by insulin in the development of endometrial cancer (EC) among Chinese premenopausal women. In this study, 128 endometrial cancer patients and 294 controls who were all premenopausal were included. Baseline characteristics data were collected and serum insulin, C-peptide, sex hormone-binding globulin, C-reaction protein, interleukin-6, and tumor necrosis factor-α levels were measured. Paired t test, χ(2) test, Spearman correlation coefficients, and univariate and multivariate logistic regression models were used in data analysis. Furthermore, insulin levels were categorized into quartiles, and likelihood ratio was calculated for the four categories. Blood insulin levels of the patients were significantly higher than those of the controls (P < 0.001). Factor analysis identified insulin (OR = 2.46; 95 % confidence interval (CI) = 1.55-3.91; P < 0.001) as the independent risk factor of EC. When insulin levels were categorized into quartiles, we found that insulin was positively associated with endometrial cancer risk [HR comparing extreme quartiles (HR q4-q1) = 4.44; 95 % CI = 2.59-7.62; P trend = 0.025]. After adjustment for body mass index (BMI) or waist-hip ratio (WHR), this association was attenuated, but still significant. In conclusion, insulin plays an important role in the carcinogenesis of EC among premenopausal women. Treatment targeting down-regulation of blood insulin levels seems effective in the prevention of this malignancy.
Department of Gynecology and Obstetrics, First People's Hospital of Laishan District, Yantai, Shandong Province, People's Republic of China, 264003.
Yanli
Y
Shao
Department of Gynecology and Obstetrics, Heze Municipal Hospital, Heze, Shandong Province, People's Republic of China, 274031.
Shijie
S
Cheng
Department of Gynecology and Obstetrics, Yantai Yuhuangding Hospital, NO 20, Yuhuangding East Road, Zhifu District, Yantai, Shandong Province, People's Republic of China, 264000.
Jianqing
J
Hou
Department of Gynecology and Obstetrics, Yantai Yuhuangding Hospital, NO 20, Yuhuangding East Road, Zhifu District, Yantai, Shandong Province, People's Republic of China, 264000.
Ying
Y
Zuo
Department of Gynecology and Obstetrics, Yantai Yuhuangding Hospital, NO 20, Yuhuangding East Road, Zhifu District, Yantai, Shandong Province, People's Republic of China, 264000.
Wei
W
Zheng
Department of Gynecology and Obstetrics, Yantai Yuhuangding Hospital, NO 20, Yuhuangding East Road, Zhifu District, Yantai, Shandong Province, People's Republic of China, 264000. xiamin0504@sohu.com.
Min
M
Xia
Department of Gynecology and Obstetrics, Yantai Yuhuangding Hospital, NO 20, Yuhuangding East Road, Zhifu District, Yantai, Shandong Province, People's Republic of China, 264000. tijmumn@live.com.
Nan
N
Mu
D000328:Adult; D014408:Biomarkers, Tumor / Q000097:blood*; D016022:Case-Control Studies; D002681:China; D016889:Endometrial Neoplasms / Q000097:blood*; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood*; D008875:Middle Aged; D017697:Premenopause; D012307:Risk Factors; D055815:Young Adult
D014408:Biomarkers, Tumor; D007328:Insulin
Case-control study; Endometrial cancer; Insulin; Premenopausal women; Risk factor